107 related articles for article (PubMed ID: 27875564)
1. Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.
Aiken T; Garber A; Thomas D; Hamon N; Lopez R; Konjeti R; McCullough A; Zein N; Fung J; Askar M; John BV
PLoS One; 2016; 11(11):e0166998. PubMed ID: 27875564
[TBL] [Abstract][Full Text] [Related]
2. IFNL4 polymorphism predicts response to hepatitis C treatment after liver transplantation.
Fernández-Carrillo C; Coto-Llerena M; González P; Crespo G; Mensa L; Caro-Pérez N; Gambato M; Navasa M; Forns X; Pérez-del-Pulgar S
J Clin Virol; 2014 Oct; 61(2):282-5. PubMed ID: 25130512
[TBL] [Abstract][Full Text] [Related]
3. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant.
Konishi H; Motomura T; Matsumoto Y; Harimoto N; Ikegami T; Yoshizumi T; Soejima Y; Shirabe K; Fukuhara T; Maehara Y
J Viral Hepat; 2014 Jun; 21(6):397-404. PubMed ID: 24750545
[TBL] [Abstract][Full Text] [Related]
4. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
[TBL] [Abstract][Full Text] [Related]
5. The relationship between IFNL4 genotype and the rate of fibrosis in hepatitis C patients.
Shridhar Gulati R; Wimalanathan T; Norheim Andersen S; Isaksen K; Lagging M; Midgard H; Moghaddam A; Dalgard O
Scand J Gastroenterol; 2019 Sep; 54(9):1172-1175. PubMed ID: 31479286
[No Abstract] [Full Text] [Related]
6. CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant.
Firpi RJ; Dong H; Clark VC; Soldevila-Pico C; Morelli G; Cabrera R; Norkina O; Shuster JJ; Nelson DR; Liu C
Liver Int; 2013 Jan; 33(1):72-8. PubMed ID: 23107586
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
Grzegorzewska AE; Mostowska A; Warchoł W; Jagodziński PP
BMC Infect Dis; 2021 Aug; 21(1):875. PubMed ID: 34445971
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.
Biggins SW; Trotter J; Gralla J; Burton JR; Bambha KM; Dodge J; Brocato M; Cheng L; McQueen M; Forman L; Chang M; Kam I; Everson G; Spritz RA; Klintmalm G; Rosen HR
J Hepatol; 2013 May; 58(5):969-76. PubMed ID: 23333445
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
[TBL] [Abstract][Full Text] [Related]
10. Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C.
Veldt BJ; Duarte-Rojo A; Thompson AJ; Watt KD; Heimbach JK; Tillmann HL; Goldstein DD; McHutchison JG; Charlton MR
Am J Transplant; 2012 Mar; 12(3):737-44. PubMed ID: 22300408
[TBL] [Abstract][Full Text] [Related]
11. Determination of IL28B polymorphisms in liver biopsies obtained after liver transplantation.
Coto-Llerena M; Crespo G; González P; Koutsoudakis G; Miquel R; Navasa M; Forns X; Pérez-del-Pulgar S
J Hepatol; 2012 Feb; 56(2):355-8. PubMed ID: 21889467
[TBL] [Abstract][Full Text] [Related]
12. Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort study.
Gadalla SM; Wang Y; Wang T; Onabajo OO; Banday AR; Obajemu A; Karaesman E; Sucheston-Campbell L; Hahn T; Sees JA; Spellman SR; Lee SJ; Katki HA; Prokunina-Olsson L
Lancet Haematol; 2020 Oct; 7(10):e715-e723. PubMed ID: 32976751
[TBL] [Abstract][Full Text] [Related]
13. [Interferon Lambda 4 RS12979860 C>T polymorphism is not associated with liver fibrosis in patients with hepatitis C].
Brahm J; Urzúa A; Poniachik J; Cáceres DD; Carreño L; Venegas M
Rev Med Chil; 2018 Jul; 146(7):823-829. PubMed ID: 30534880
[TBL] [Abstract][Full Text] [Related]
14. The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation.
Allam SR; Krüger B; Mehrotra A; Schiano T; Schröppel B; Murphy B
PLoS One; 2013; 8(1):e54854. PubMed ID: 23382988
[TBL] [Abstract][Full Text] [Related]
15. Impact of IFNL4-∆G genotype on sustained virologic response in hepatitis C genotype 1 patients treated with direct-acting antivirals.
Backus LI; Shahoumian TA; Belperio PS; Winters M; Prokunina-Olsson L; O'Brien TR; Holodniy M
Diagn Microbiol Infect Dis; 2018 Sep; 92(1):34-36. PubMed ID: 29866411
[TBL] [Abstract][Full Text] [Related]
16. A Simple PCR-RFLP Method for Genotyping of IFNL4 rs368234815 Polymorphism in Patients With Chronic Hepatitis C.
Pouryasin M; Sharafi H; Behnava B; Alavian SM; Keshvari M; Pouryasin A
Lab Med; 2017 Feb; 48(1):51-56. PubMed ID: 28057801
[TBL] [Abstract][Full Text] [Related]
17. Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
Amanzada A; Kopp W; Spengler U; Ramadori G; Mihm S
PLoS One; 2013; 8(12):e84026. PubMed ID: 24376784
[TBL] [Abstract][Full Text] [Related]
18. Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.
Petta S; Valenti L; Tuttolomondo A; Dongiovanni P; Pipitone RM; Cammà C; Cabibi D; Di Marco V; Fracanzani AL; Badiali S; Nobili V; Fargion S; Grimaudo S; Craxì A
Hepatology; 2017 Dec; 66(6):1885-1893. PubMed ID: 28741298
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.
Amanzada A; Reinhardt L; Fey D; Zeisberg EM; Mihm S
PLoS One; 2015; 10(11):e0143783. PubMed ID: 26606750
[TBL] [Abstract][Full Text] [Related]
20. Impact of donor histology on survival following liver transplantation for chronic hepatitis C virus infection: a Scandinavian single-center experience.
Ydreborg M; Westin J; Lagging M; Castedal M; Friman S
Scand J Gastroenterol; 2012 Jun; 47(6):710-7. PubMed ID: 22452366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
